Free CME from PeerView


Neurology CME

Credits: 1.0 CME / CPE
PVI, PeerView Institute for Medical Education
Taking the Pulse of Undiagnosed Atrial Fibrillation: Pharmacists as a Lynchpin of Detection and Team-Based Care
May 06, 2022
Credits: 0.5 CME / NCPD
Medical Learning Institute, Inc.
Breakthroughs in Spinal Muscular Atrophy: Managing the Life-Changing Impact of Gene Replacement Therapy
March 01, 2022
Credits: 0.5 CME
Penn State College of Medicine
Leveraging S1PR Modulators to Provide Patient-Centered MS Care: An Expert-Driven Review of the Data
February 28, 2022
Amit Bar-Or, MD, FRCPC/Daniel S. Reich, MD, PhD
Credits: 1.0 CME
Medical Learning Institute, Inc.
Rationale, Evidence, and Practical Potential for BTK Inhibitors in Patient-Centered MS Care: Where We Stand Now
February 26, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Putting the Pieces Together: Would You Recognize Acute Hepatic Porphyria If You Saw It?
February 25, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
The Expanding Role of Neuroimaging in Alzheimer’s Disease Diagnosis and Management: Is Radiology Prepared for New Challenges?
February 15, 2022
Gregory W. Albers, MD/S. Claiborne “Clay” Johnston, MD, PhD
Credits: 1.5 CME
Medical Learning Institute, Inc.
Mastering the Use of Dual Antiplatelet Therapy for Preventing Recurrent Stroke: How Well Do Your Current Strategies Match With the Experts?
February 10, 2022
Bradley S. Miller, MD, PhD
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Advances in Pediatric Growth Hormone Therapy: Visualizing the Impact on Individualized Care
December 30, 2021
Credits: 1 CME / NCPD / CPE
Medical Learning Institute, Inc.
Bruton Tyrosine Kinase Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach
October 28, 2021
Credits: 1 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Exploring the Convergence of Advances in S1P Receptor Modulation With Progress in Understanding Brain Atrophy and Cognition Measures in Multiple Sclerosis
October 26, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
On the Cusp of a New Targeted Treatment Era in ALS: Exploring the Emerging Therapeutic Landscape
October 22, 2021
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
July 15, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Dawn of a New Era: Recent Advances in the Pharmacologic Management of Idiopathic Hypersomnia
June 25, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Managing Motor Complications in Parkinson’s Disease: Evaluating the Role of On-Demand Therapies for “Off” Episodes
June 22, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Advancing the Treatment of Pompe Disease: Clinical Updates in Newborn Screening and Enzyme Replacement
June 10, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of Antisense Oligonucleotide Therapies in Amyotrophic Lateral Sclerosis
June 08, 2021
Medical Learning Institute, Inc.
The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
May 18, 2021
Medical Learning Institute, Inc.
A New Era of Migraine Management: Recent Updates on Recognition, Acute Treatment, and Prevention for Emergency Physicians
May 03, 2021
Medical Learning Institute, Inc.
Data-Based Updates: Practical Application of Recent Evidence on Disease-Modifying Therapies for SMA
March 30, 2021
Medical Learning Institute, Inc.
Expert Perspectives on the Early Diagnosis of Alzheimer’s Disease and the Promise of Novel Therapies on the Horizon
March 22, 2021
Anne H. Cross, MD, FAAN / Prof. Xavier Montalban
Medical Learning Institute, Inc.
Exploring the Rationale, Results, and Real-World Clinical Potential of BTK Inhibitors in the Management of Multiple Sclerosis
February 01, 2021
Maria K. Houtchens, MD, MMs
Medical Learning Institute, Inc.
MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies
January 22, 2021
Medical Learning Institute, Inc.
Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
December 31, 2020

Pages